EUVIMEDEUVIMED entdecken
Crossref

Bruceine A inhibited breast cancer proliferation and metastasis by inducing autophagy via targeting PI3K‐AKT signaling pathway

Zhen Gao, Yan Zhang, Weixing Shen, Xinyu Liu, Yunfang Wei, Linxia Li iD, Hengguan Cui

Chemical Biology & Drug Design · 2024

DOI: 10.1111/cbdd.14398 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2024. Verfasst von Zhen Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Proto-Oncogene Proteins c-akt, Neoplasms, Quassins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 21 Literaturangaben. Gefördert von: Pudong New Area Key Specialist Construction Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although there have been significant advances in cancer treatment, the urgent need to inhibit breast cancer metastasis remained unmet. Bruceine A (BA) is a natural compound extracted from Bruceae Fructus and has long been recognized to have antitumor effects with high safety and biocompatibility. However, the mechanisms and/or targets of BA for metastatic breast cancer treatment are still not fully elucidated. In this study, we systematically investigated the effects of BA on inhibition of breast cancer metastasis and its underlying mechanisms. We found that, in addition to its cytotoxic effects, BA significantly inhibited the invasion and migration capabilities of two types of breast cancer cell lines (MDA‐MB‐231 and MCF‐7) while concurrently promoting apoptosis in these cells. Further mechanistic studies revealed that, by targeting the canonical PI3K‐AKT signaling pathway, BA initiated autophagy of both types of breast cancer cell lines in vitro. In vivo results further confirmed the in vitro findings, manifested by shrinkage of size and weight of breast tumor as well as initiation of autophagy (indicated by upregulation of LC3I/II) through targeting PI3K‐AKT pathway on mice model. These data collectively demonstrated the potential of BA in antimetastasis of breast cancer cells, suggesting its future clinical transformation in metastatic breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proto-Oncogene Proteins c-aktNeoplasmsQuassinsAnimalsMicePhosphatidylinositol 3-KinasesTOR Serine-Threonine KinasesCell ProliferationSignal TransductionAutophagyApoptosisCell Line, Tumor

Stichwörter der Autor:innen

Bruceine API3K-AKT signaling pathwayapoptosisautophagybreast cancer

Substanzen

Proto-Oncogene Proteins c-aktPhosphatidylinositol 3-Kinasesbruceine ATOR Serine-Threonine KinasesQuassins

Autor:innen und Institutionen

  • Department of General Surgery, Qingpu Branch of Zhongshan Hospital, Fudan University, Shanghai, China.
  • Department of Gynecology, Seventh People's Hospital of Shanghai University of Traditional Chinese Medicine, Shanghai, China.

ORCID-Profile: Linxia Li

Förderung

  • Pudong New Area Key Specialist Construction Project

Zitieren

APA

Gao, Z., Zhang, Y., Shen, W., Liu, X., Wei, Y., Li, L., & Cui, H. (2024). Bruceine A inhibited breast cancer proliferation and metastasis by inducing autophagy via targeting PI3K‐AKT signaling pathway. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.14398

Vancouver

Gao Z, Zhang Y, Shen W, Liu X, Wei Y, Li L, et al. Bruceine A inhibited breast cancer proliferation and metastasis by inducing autophagy via targeting PI3K‐AKT signaling pathway. Chemical Biology & Drug Design. 2024. doi:10.1111/cbdd.14398

BibTeX
@article{Gao2024,
  author = {Gao, Zhen and Zhang, Yan and Shen, Weixing and Liu, Xinyu and Wei, Yunfang and Li, Linxia and Cui, Hengguan},
  title = {Bruceine A inhibited breast cancer proliferation and metastasis by inducing autophagy via targeting PI3K‐AKT signaling pathway},
  journal = {Chemical Biology & Drug Design},
  year = {2024},
  doi = {10.1111/cbdd.14398}
}
Kostenlos starten →